Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia
dc.contributor.author | Kitchen, Brenda J. | en_US |
dc.contributor.author | Boxer, Laurence A. | en_US |
dc.date.accessioned | 2007-12-04T18:36:40Z | |
dc.date.available | 2009-01-07T20:01:15Z | en_US |
dc.date.issued | 2008-01 | en_US |
dc.identifier.citation | Kitchen, Brenda J.; Boxer, Laurence A. (2008). "Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia." Pediatric Blood & Cancer 50(1): 142-145. <http://hdl.handle.net/2027.42/57398> | en_US |
dc.identifier.issn | 1545-5009 | en_US |
dc.identifier.issn | 1545-5017 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/57398 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16767728&dopt=citation | en_US |
dc.description.abstract | We describe a female with a history of autosomal recessive hyper-IgM (HIGM) syndrome along with a history of autoimmune hemolytic anemia and intermittent lymphadenopathy. She subsequently developed neutropenia, lymphocyostosis and mild thrombocytopenia. Flow cytometry of the peripheral blood revealed the presence of a marked predominance of cytotoxic T lymphocytes, shown to be clonal, with concomitant natural killer (NK) antigen expression. She responded to weekly methotrexate therapy. Pediatr Blood Cancer 2008;50:142–145. © 2006 Wiley-Liss, Inc. | en_US |
dc.format.extent | 106489 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Hematology/Oncology, Department of Pediatrics and Communicable Diseases, University of Michigan, Mott Children's Hospital, Ann Arbor, Michigan ; Women's Hospital Rm L2110, 1500 E. Medical Center Dr., Box 0238, Ann Arbor, MI 48109. | en_US |
dc.contributor.affiliationum | Division of Hematology/Oncology, Department of Pediatrics and Communicable Diseases, University of Michigan, Mott Children's Hospital, Ann Arbor, Michigan | en_US |
dc.identifier.pmid | 16767728 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/57398/1/20902_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/pbc.20902 | en_US |
dc.identifier.source | Pediatric Blood & Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.